BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01532089-completion@plaintrial.com
DTSTAMP:20261028T161046Z
DTSTART;VALUE=DATE:20200818
SUMMARY:Erlotinib Hydrochloride With or Without Bevacizumab in Treating Pat
 ients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Facto
 r Receptor Mutations — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01532089
URL:https://plaintrial.com/trial/NCT01532089
END:VEVENT
END:VCALENDAR